A simple sample size formula for analysis of covariance in randomized clinical trials
Top Cited Papers
- 31 December 2007
- journal article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 60 (12), 1234-1238
- https://doi.org/10.1016/j.jclinepi.2007.02.006
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- ANCOVA versus change from baseline had more power in randomized studies and more bias in nonrandomized studiesJournal of Clinical Epidemiology, 2006
- Randomized Controlled Trials With Time-to-Event Outcomes: How Much Does Prespecified Covariate Adjustment Increase Power?Annals of Epidemiology, 2006
- When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?Annals Of The Rheumatic Diseases, 2005
- Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirementsJournal of Clinical Epidemiology, 2004
- Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failedAnnals Of The Rheumatic Diseases, 2004
- Evaluation of the results of a randomized controlled trial: how to define changes between baseline and follow-upJournal of Clinical Epidemiology, 2004
- Power in randomized group comparisons: The value of adding a single intermediate time point to a traditional pretest-posttest design.Psychological Methods, 2002
- Statistics Notes: Analysing controlled trials with baseline and follow up measurementsBMJ, 2001
- How to Select Covariates to Include in the Analysis of a Clinical TrialControlled Clinical Trials, 2000
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995